title: Rationale for OKT3 monoclonal antibody treatment in transplant patients.
authors: Laboratory of Immunogenetics and Transplantation, Oregon Health Sciences University, Portland 97201.
authors: D J
authors: DJ
authors: Norman
mesh_terms: D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D014181:Transplantation Immunology
chemical_list: D016853:Muromonab-CD3